Showing results (351-360 of 586) with videos related to
Sort By:
Pageof 59
Oncology (Williston Park, N.Y.)|February 28, 2001
Docetaxel followed by gemcitabine and irinotecan in solid tumorsC M Rocha Lima, J J Urbanic, C A Sherman, et al.Rapid Communications in Mass Spectrometry : RCM|January 1, 1995
Comparison of fragmentation modes for the structural determination of complex oligosaccharides ionized by matrix-assisted laser desorption/ionization mass spectrometryD J Harvey, T J Naven, B Küster, et al.Genomics|April 15, 1996
The gene for human U2 snRNP auxiliary factor small 35-kDa subunit (U2AF1) maps to the progressive myoclonus epilepsy (EPM1) critical region on chromosome 21q22.3M D Lalioti, A Gos, M R Green, et al.International Journal of Cancer|March 12, 1998
Co-ordinated over-expression of the MRP and gamma-glutamylcysteine synthetase genes, but not MDR1, correlates with doxorubicin resistance in human malignant mesothelioma cell linesB Ogretmen, H R Bahadori, M D McCauley, et al.Cancer Research|January 19, 1999
A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancerY K Tran, O Bögler, K M Gorse, et al.The Journal of Cell Biology|June 2, 1997
Targeting of U2AF65 to sites of active splicing in the nucleusM Gama-Carvalho, R D Krauss, L Chiang, et al.Nucleic Acids Research|September 25, 1984
Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoterD A Melton, P A Krieg, M R Rebagliati, et al.Nature|July 23, 1992
Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2S J Kim, S Wagner, F Liu, et al.International Journal of Radiation Oncology, Biology, Physics|July 30, 1994
Alternating irradiation and chemotherapy in stage III A and B nonsmall cell lung cancer: report of a cancer and Leukemia Group B phase II study 8636S L Seagren, J E Herndon, J R Baeker, et al.Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group BH L Kindler, F Millard, J E Herndon, et al.Pageof 59